Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer

NCT01034189 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Cetuximab
DRUG: Paclitaxel
DRUG: Cisplatin
RADIATION: Radiotherapy

Sponsor

National Taiwan University Hospital